SCHEMBL18927106

SCHEMBL18927106

C[C@]12CC(=O)C3C(CCC4=CC(=O)CC[C@@]43C)C1CCC2C(=O)O

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SERPINA6 P08185 4/20 0.85
▸ FNTA P49354 1/20 0.69
▸ FNTB P49356 1/20 0.69
▸ SMN1; SMN2 Q16637 7/20 0.61
▸ LMNA P02545 6/20 0.61
▸ POLB P06746 1/20 0.61
▸ CYP3A4 P08684 6/20 0.61
▸ ALDH1A1 P00352 6/20 0.61
▸ MAPT P10636 4/20 0.61
▸ MAPK1 P28482 4/20 0.61
▸ TSHR P16473 3/20 0.61
▸ SHBG P04278 3/20 0.61
▸ CYP2C9 P11712 2/20 0.61
▸ HIF1A Q16665 2/20 0.61
▸ NR3C2 P08235 2/20 0.61
▸ NR3C1 P04150 2/20 0.61
▸ PMP22 Q01453 2/20 0.61
▸ ABCB11 O95342 2/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ KDM4E B2RXH2 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9348241 1.00 SERPINA6 (0.85) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL9348234 1.00 SERPINA6 (0.85) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL15920543 0.92 SERPINA6 (1.00) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL14420894 0.92 SERPINA6 (1.00) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL668966 0.92 SERPINA6 (1.00) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL15904593 0.92 SERPINA6 (1.00) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL14525642 0.92 SERPINA6 (1.00) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL6347180 0.90 SERPINA6 (0.84) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL31095098 0.89 SERPINA6 (0.82) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL5497592 0.88 SERPINA6 (0.80) SERPINA6FNTAFNTBSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542298-B2 Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof EPIRIUM BIO INC. (US) 2023-01-03 — — US disclosed
EP-3795578-A2 HYDROXYSTEROID COMPOUNDS, THEIR INTERMEDIATES, PROCESS OF PREPARATION, COMPOSITION AND USES THEREOF Sphaera Pharma Pvt. Ltd. (IN) 2021-03-24 — — EP disclosed
US-20210024572-A1 HYDROXYSTEROID COMPOUNDS, THEIR INTERMEDIATES, PROCESS OF PREPARATION, COMPOSITION AND USES THEREOF EPIRIUM BIO INC. 2021-01-28 — — US disclosed
EP-3171855-B1 11.BETA.-HYDROXYSTEROID-4-AZA-COMPOUNDS, COMPOSITIONS AND USES THEREOF SPHAERA PHARMA PRIVATE LTD (IN) 2020-08-26 — — EP disclosed
US-20170158730-A1 HYDROXYSTEROID COMPOUNDS, THEIR INTERMEDIATES, PROCESS OF PREPARATION, COMPOSITION AND USES THEREOF SPHAERA PHARMA PVT. LTD. (IN) 2017-06-08 — — US disclosed
US-20170158730-A1 HYDROXYSTEROID COMPOUNDS, THEIR INTERMEDIATES, PROCESS OF PREPARATION, COMPOSITION AND USES THEREOF SPHAERA PHARMA PVT. LTD. (IN) 2017-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11542298-B2 Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof HSD17B7, HSD11B1, HSD3B1 SERPINA6 139/4885FNTA 219/4885FNTB 458/4885
US-20170158730-A1 HYDROXYSTEROID COMPOUNDS, THEIR INTERMEDIATES, PROCESS OF PREPARATION, COMPOSITION AND USES THEREOF HSD17B7, HSD11B1, HSD3B1 SERPINA6 139/4885FNTA 219/4885FNTB 458/4885
US-20210024572-A1 HYDROXYSTEROID COMPOUNDS, THEIR INTERMEDIATES, PROCESS OF PREPARATION, COMPOSITION AND USES THEREOF HSD17B7, HSD11B1, HSD3B1 SERPINA6 139/4885FNTA 219/4885FNTB 458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback